Warfarin Sodium
- Product NDC
- 51672-4031
- Requested package NDC
- 51672-4031-0
- 11-digit product format
- 516724031
- Labeler code
- 51672
- Product ID
- 51672-4031_373f3fe2-c159-028e-e063-6394a90aff59
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Warfarin Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA040301
- Marketing category
- ANDA
- Marketing start
- 1999-07-15
- Substance
- WARFARIN SODIUM
- Active strength
- 4 mg/1
- Pharmacologic classes
- Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 51672-4031 | 51672-4031-0 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040301-001 | WARFARIN SODIUM | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 1999-07-15 | |
| A040301-002 | WARFARIN SODIUM | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 1999-07-15 | |
| A040301-003 | WARFARIN SODIUM | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 1999-07-15 | |
| A040301-004 | WARFARIN SODIUM | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 1999-07-15 | |
| A040301-005 | WARFARIN SODIUM | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 1999-07-15 | |
| A040301-006 | WARFARIN SODIUM | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 1999-07-15 | |
| A040301-007 | WARFARIN SODIUM | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 1999-07-15 | |
| A040301-008 | WARFARIN SODIUM | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 1999-07-15 | |
| A040301-009 | WARFARIN SODIUM | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 1999-07-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040301-001 | AB |
| A040301-002 | AB |
| A040301-003 | AB |
| A040301-004 | AB |
| A040301-005 | AB |
| A040301-006 | AB |
| A040301-007 | AB |
| A040301-008 | AB |
| A040301-009 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040301-001 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 1999-07-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040301-002 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 1999-07-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040301-003 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 1999-07-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040301-004 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 1999-07-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040301-005 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 1999-07-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040301-006 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 1999-07-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040301-007 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 1999-07-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040301-008 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 1999-07-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040301-009 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 1999-07-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040301-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040301-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040301-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040301-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040301-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040301-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040301-007 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040301-008 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040301-009 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Warfarin Sodium | WARFARIN SODIUM | A-S Medication Solutions | 8cd0e744-b499-4344-b1db-59f85950e169 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | A-S Medication Solutions | 991b1e3e-236e-44cf-ad61-7233f777ce67 | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | REMEDYREPACK INC. | 6b227c9e-02e9-4ec9-8b11-3ab6fe5093e5 | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | REMEDYREPACK INC. | 72d3ea20-27e4-4368-a666-a9b76530dbb9 | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | REMEDYREPACK INC. | 61ab23a7-bc67-4777-854a-bf43c788a69a | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | REMEDYREPACK INC. | 7b3b6f89-1feb-4939-a95b-7ad0707f4d76 | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | REMEDYREPACK INC. | 73b8e5ab-86f8-44f8-b290-346acb81c9ae | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | Cardinal Health 107, LLC | cdbbc317-35d3-42ba-94f0-c83891358529 | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | Bryant Ranch Prepack | 694e258d-86bd-440c-870b-a7d27fb1c467 | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | Golden State Medical Supply, Inc. | ba8b4ead-d080-91e7-e053-2995a90a82fe | 2025-07-10 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | Sun Pharmaceutical Industries, Inc. | 8ad881e0-ca41-42ad-9d7d-eb85b3a30af0 | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 51672-4031-0 51672-4031 51672403100 |
| Warfarin Sodium | WARFARIN SODIUM | Cardinal Health 107, LLC | 7c4deb97-9966-4c8e-9ba6-bb260b71e130 | 2025-06-03 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | American Health Packaging | ab047628-67d0-4a64-8d77-36b054969b44 | 2024-10-04 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | American Health Packaging | feaa5f6f-9753-4f37-ab81-04c9c6b45e6a | 2024-10-04 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | Aphena Pharma Solutions - Tennessee, LLC | e73d37f8-8a28-4d93-9529-fd1e2c84228a | 2021-08-17 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
| Warfarin Sodium | WARFARIN SODIUM | Aphena Pharma Solutions - Tennessee, LLC | 2c8f47c6-a180-4ad8-b962-04069d2270cb | 2021-07-29 | Boxed warning, Warnings, Adverse reactions | 040301 ANDA040301 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Warfarin Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| WARFARIN SODIUM | 4 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6153CWM0CL | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 855288 | Internal RxNorm lookup |
| 855296 | Internal RxNorm lookup |
| 855302 | Internal RxNorm lookup |
| 855312 | Internal RxNorm lookup |
| 855318 | Internal RxNorm lookup |
| 855324 | Internal RxNorm lookup |
| 855332 | Internal RxNorm lookup |
| 855338 | Internal RxNorm lookup |
| 855344 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8ad881e0-ca41-42ad-9d7d-eb85b3a30af0 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| abcfe2f4-1eca-fdc3-341b-b8134a1aec1f | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4031-0 | Warfarin Sodium | 10 in 1 BLISTER PACK | TABLET | 10 | 14 | |
| 51672-4031-0 | Warfarin Sodium | 10 in 1 CARTON | TABLET | 10 | 14 | |
| 51672-4031-1 | Warfarin Sodium | 100 in 1 BOTTLE | TABLET | 100 | 14 | |
| 51672-4031-3 | Warfarin Sodium | 1000 in 1 BOTTLE | TABLET | 1000 | 14 | |
| 51672-4031-7 | Warfarin Sodium | 5000 in 1 BOTTLE | TABLET | 5000 | 14 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4031-1 | EA - Each | 51672-4031 | 4b6beccb-4418-43cf-b8ed-cd8bc68a1d29 | 1 | 2012-07-24 |
| 51672-4031-3 | EA - Each | 51672-4031 | ee68b21a-50a3-4315-a10c-8622b87bee24 | 1 | 2012-07-24 |
| 51672-4031-7 | EA - Each | 51672-4031 | 3c59749c-c230-4bbd-bc84-1abbd2d6505e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4031 | WARFARIN SODIUM TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 13 | Current NDC, Legacy NDC, 5 package rows | 20231222_8ad881e0-ca41-42ad-9d7d-eb85b3a30af0.zip |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 51672-4031-0 | 51672403100 | 10 BLISTER PACK in 1 CARTON (51672-4031-0) > 10 TABLET in 1 BLISTER PACK | 10 blister pack | 1999-07-15 | 0000-00-00 | No | No | Current |